COMPARATIVE IMMUNOGENICITY OF BNT162b2 mRNA VACCINE WITH NATURAL COVID-19 INFECTION

MLA

Pagona Lagiou, et al. COMPARATIVE IMMUNOGENICITY OF BNT162b2 MRNA VACCINE WITH NATURAL COVID-19 INFECTION. June 2021. EBSCOhost, https://doi.org/10.1101/2021.06.15.21258669.

APA

Pagona Lagiou, Irene Eliadi, Elpida Mastrogianni, Anastasia Kotanidou, Dimitrios Paraskevis, Maria Pratikaki, Konstantinos N. Syrigos, Dimitrios Basoulis, Mina Psichogiou, Antigoni Chaidaroglou, Konstantinos Petsios, Edison Jahaj, Angelos Hatzakis, Dimitrios Degiannis, Andreas Karabinis, Garyphallia Poulakou, Ioanna D. Pavlopoulou, Sotirios Roussos, Anastasia Antoniadou, … Gkikas Magiorkinis. (2021). COMPARATIVE IMMUNOGENICITY OF BNT162b2 mRNA VACCINE WITH NATURAL COVID-19 INFECTION. https://doi.org/10.1101/2021.06.15.21258669

Chicago

Pagona Lagiou, Irene Eliadi, Elpida Mastrogianni, Anastasia Kotanidou, Dimitrios Paraskevis, Maria Pratikaki, Konstantinos N. Syrigos, et al. 2021. “COMPARATIVE IMMUNOGENICITY OF BNT162b2 MRNA VACCINE WITH NATURAL COVID-19 INFECTION,” June. doi:10.1101/2021.06.15.21258669.